ซื้อสินค้าแท้ในออสเตรเลีย จัดส่งฟรีทุกรัฐ บริการลูกค้า WhatsApp
Get started in 3 simple steps — no clinic visits required
Complete a brief health assessment. Our licensed physicians review your medical history and determine if GLP-1 therapy is right for you.
If approved, your doctor prescribes your personalized treatment plan with the right medication and dosage for your goals.
Your medication is compounded by a US-licensed pharmacy and shipped directly to you with everything you need to get started.
FDA-regulated compounded medications at a fraction of brand-name cost
Begin your weight loss journey with our lowest starter dose. Compounded Semaglutide 0.25mg/week injection, prescribed by US-licensed physicians. Includes alcohol swabs, syringes, and detailed instructions.
Mid-range dose for continued weight loss. Compounded Semaglutide 0.5mg/week injection after successful 0.25mg titration. Clinically proven to reduce appetite and food intake.
Full therapeutic dose for maximum weight loss results. Compounded Semaglutide 1.0mg/week. Average patients lose 15% body weight in clinical trials. Continue with medical supervision.
Highest available dose for patients who need maximum suppression. Compounded Semaglutide 2.4mg/week injection. Only available after physician review of treatment history.
Start with the dual GIP/GLP-1 receptor agonist. Compounded Tirzepatide 2.5mg/week, shown to achieve up to 22% body weight loss. Includes all injection supplies.
Standard therapeutic dose of dual-action weight loss medication. Compounded Tirzepatide 5.0mg/week. Enhanced efficacy through dual GIP and GLP-1 receptor activation.
Higher dose Tirzepatide for patients requiring stronger appetite suppression. Compounded Tirzepatide 10mg/week injection. Prescribed after successful dose titration.
Maximum therapeutic dose achieving the highest weight loss outcomes. Compounded Tirzepatide 15mg/week. Clinical trials showed average 22.5% body weight reduction at this dose.
Everything you need to start: 4-week supply of Compounded Semaglutide 0.25mg, bacteriostatic water, syringes, alcohol swabs, sharps container, and a comprehensive getting-started guide. Doctor consultation included.
Complete 3-month titration package: Month 1 (0.25mg), Month 2 (0.5mg), Month 3 (1.0mg). Includes all supplies, monthly check-in with physician, and personalized nutrition guide. Save $87 vs individual orders.
Every medication meets the highest standards of safety and traceability
503A/503B compounding facility with full regulatory oversight
Every prescription reviewed by licensed US physicians
Independent HPLC purity analysis on every batch
Certificate of Analysis available for every product batch
End-to-end encrypted health data protection
Real results from real patients on their weight loss journey
After 3 months on Semaglutide I lost 32 lbs. Online consultation, prescription in 24 hours, medication at my door in 3 days. Life changing!
Down 45 lbs in 5 months. My doctor was amazed — cholesterol, blood sugar, blood pressure all improved. Compounded medication works exactly like brand name at a fraction of cost.
Switched from Ozempic ($1200/mo) to compounded Semaglutide — same results for $129/month. WhatsApp support answered all my questions.
Lost 18 lbs in 2 months. Some nausea first week but passed quickly. The titration schedule they recommended was perfect for managing side effects.
Tried Tirzepatide after plateauing on Semaglutide — lost another 20 lbs in 6 weeks. The dual-action mechanism really works differently. Incredible!
Start your medically supervised weight loss journey today. No clinic visits. No insurance needed.
FDA Disclaimer: These compounded medications are not FDA-approved drugs. They are prepared by a licensed compounding pharmacy pursuant to a valid prescription. Individual results may vary. This website does not provide medical advice, diagnosis, or treatment. Consult your physician before starting any weight loss program. GLP-1 receptor agonists carry risks including nausea, vomiting, diarrhea, and potential thyroid concerns. Not recommended for individuals with a history of medullary thyroid carcinoma or MEN2.